Dawei Ding

Suzhou, 215123, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Dissolving microneedle delivery of anemoside B4: a strategy to enhance therapeutic efficacy against psoriasis.

Dissolving microneedle delivery of anemoside B4: a strategy to enhance therapeutic efficacy against psoriasis.

Journal: Drug delivery and translational research

Published: March 26, 2026

Acriflavine-empowered IR780-PTX albumin nanoparticles for reinforced synergistic photochemotherapy.

Acriflavine-empowered IR780-PTX albumin nanoparticles for reinforced synergistic photochemotherapy.

Journal: Advanced biotechnology

Published: December 14, 2025

Bidirectionally H2O2-suppliable and antioxidant-consumable copper peroxide nanoparticles for photochemodynamic immunotherapy.

Bidirectionally H2O2-suppliable and antioxidant-consumable copper peroxide nanoparticles for photochemodynamic immunotherapy.

Journal: Biomaterials

Published: September 25, 2025

TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial.

TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial.

Journal: Med (New York, N.Y.)

Published: May 08, 2025

A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study.

A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study.

Journal: European journal of pharmacology

Published: April 03, 2025

Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy.

Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy.

Journal: Materials today. Bio

Published: December 10, 2024

Association between Perfluoroalkyl and polyfluoroalkyl substances exposure and hypercholesterolemia among U.S. adults: A cross-sectional study.

Association between Perfluoroalkyl and polyfluoroalkyl substances exposure and hypercholesterolemia among U.S. adults: A cross-sectional study.

Journal: Ecotoxicology and environmental safety

Published: December 04, 2024

Core-shell vector-mediated co-delivery of CRISPR/Cas9 system and hydrophobic drugs against triple-negative breast cancer stem cells.

Core-shell vector-mediated co-delivery of CRISPR/Cas9 system and hydrophobic drugs against triple-negative breast cancer stem cells.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 26, 2024

Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects.

Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects.

Journal: Cancer chemotherapy and pharmacology

Published: December 29, 2023

Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief.

Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: November 01, 2023

Recent Advances of Tumor Microenvironment-Responsive Nanomedicines-Energized Combined Phototherapy of Cancers.

Recent Advances of Tumor Microenvironment-Responsive Nanomedicines-Energized Combined Phototherapy of Cancers.

Journal: Pharmaceutics

Published: August 28, 2023

Steerable Microneedles Enabling Deep Delivery of Photosensitizers and CRISPR/Cas9 Systems for Effective Combination Cancer Therapy.

Steerable Microneedles Enabling Deep Delivery of Photosensitizers and CRISPR/Cas9 Systems for Effective Combination Cancer Therapy.

Journal: Nano letters

Published: August 18, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026